Fentanyl and Ketamine Therapy | Tovani Health
Duragesic (Fentanyl) (also: Actiq, Subsys) — Potent opioid analgesic (mu-receptor agonist)
Verdict at Tovani Health
Evaluate carefully; potency raises the respiratory-depression stakes meaningfully.
Fentanyl alongside ketamine requires individual evaluation. Fentanyl is 50-100x more potent than morphine, and the respiratory-depression risk in combination with ketamine is materially higher than with weaker opioids. Patients on transdermal fentanyl for chronic cancer pain may still be candidates with extra monitoring; patients on rapid-onset formulations (Actiq, Subsys) need particularly careful planning.
If you take Duragesic regularly and are considering at-home ketamine therapy, the combination is depends on your specific situation. This page covers the brief pharmacologic context and what we do at intake.
How Duragesic interacts with ketamine
Fentanyl is a highly potent synthetic mu-opioid agonist. The combination with ketamine's CNS depression has a narrower margin of safety than weaker opioids.
What we do at intake
Disclose dose, formulation, indication, and prescriber. We evaluate every fentanyl patient individually and may decline at-home KAP in favor of supervised in-clinic settings.
Bottom line
Fentanyl alongside ketamine requires individual evaluation. Fentanyl is 50-100x more potent than morphine, and the respiratory-depression risk in combination with ketamine is materially higher than with weaker opioids. Patients on transdermal fentanyl for chronic cancer pain may still be candidates with extra monitoring; patients on rapid-onset formulations (Actiq, Subsys) need particularly careful planning.
Frequently Asked Questions
I have a fentanyl patch for chronic pain. Am I a candidate for at-home KAP?
Possibly. We evaluate individually. For some patients we recommend supervised in-clinic ketamine rather than at-home protocols.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Duragesic (Fentanyl) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Sources
The verdict and clinical guidance on this page are based on the following peer-reviewed literature and FDA prescribing information.
- Ketamine as an adjuvant to opioids for cancer pain. Bell RF, Eccleston C, Kalso EA.. Cochrane Database of Systematic Reviews. 2017. PMID: 28657160
Cochrane systematic review evaluating ketamine added to opioid therapy for cancer pain.
- Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism. Williams NR, Heifets BD, Blasey C, et al.. American Journal of Psychiatry. 2018. PMID: 30153752
Landmark study showing pretreatment with naltrexone (opioid receptor antagonist) blocks the antidepressant effect of ketamine.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 16, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.